IHL
Click for more information
0.00% 4.1¢ incannex healthcare limited

Ann: Update on Nasdaq Listing, page-149

  1. Zacsydney
    3,182 Posts.
    lightbulb Created with Sketch. 624
    clock Created with Sketch.
    13/01/22
    23:34
    Post #: 58850540
    https://*********.com.au/incannex-healthcare-study-lead-drug-ihl-675a-anti-inflammatory-capabilities/

    Excellent article about our success in treating lung conditions, asthma, chronic inflammatory lung disease and bronchitis.

    .Are they now applying for FDA approval as these were successful trials from what I read .. the next step would be approval then producing the treatments.

    IHL Price at posting: 65.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
SVL Silver Mines models five new calderas close to 396Moz Bowdens deposit
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.